Visit COVID-19 resources

[Skip to Content]

Consultation on Treating Retinopathy of Prematurity in the UK

21 October 2021

The Royal College of Ophthalmologists (RCOphth) has produced a new draft clinical guideline on The Treatment of Retinopathy of Prematurity (ROP) in the UK.

This evidence-based guideline for the treatment of ROP was developed by a guideline development group (GDG) of the RCOphth chaired by Miss Gill Adams, the UK special interest group of ROP screeners and treaters (ROP-SIG) and the charity Bliss.

Retinopathy of prematurity

Retinopathy of prematurity (ROP) is a potentially blinding condition affecting low gestation and low birth weight babies. Worldwide it is a major cause of preventable blindness. Screening for ROP is undertaken to identify ROP that requires treatment.

Aims of the updated guideline

The guideline has been produced for use within the UK and supersedes the guideline published in 2008.

The aims of the guideline are:

  1. To evaluate and summarise the clinical evidence relating to the treatment of ROP.
  2. To provide evidence-based recommendations for the treatment of ROP.
  3. To provide information for parents and carers on the treatment of ROP.
  4. To produce good practice points based on the consensus of the Guideline Development Group (GDG) in areas where the research evidence is lacking.

Consultation process

The College would now welcome any comments or observations on the content, format, or recommendations in this new guidance, to help contribute to and influence the final guideline.

We would particularly like to hear about additional sources of evidence, which the GDG may wish to consider, or views on alternative interpretation of the evidence which may lead to a rephrasing or amendment of the recommendations.

We would be grateful if you could provide your comments by 22 November 2021.

Please send your comments to Barny Foot at [email protected]

Barny can also be contacted if you have any questions.

Consultation documents

The consultation documents outline key recommendations and good practice points for implementation, current practice and why there is scope for change, and the process used to develop this guideline.

Download key documents relating to this consultation:

More information about RCOphth guidelines

Our guidelines are systematically generated to help clinicians make better decisions about appropriate healthcare for specific eye disorders, enhancing clinician and patient decision making by describing and appraising the scientific evidence and reasoning behind clinical recommendations.

Read RCOphth guidelines

RCOphth guideline recommendations are agreed via consensus of the guideline development group (GDG). In addition, we undertake consultation with key stakeholders to ensure high-quality Ophthalmology can be practised in the UK health service. International eye care practitioners may also find our guidelines useful to support their practice.